RPN2 Predicts Poor Prognosis and Promotes Bladder Cancer Growth and Metastasis via the PI3K-Akt Pathway.

Chenglin HanShuxiao ChenHaiyang MaXiangchuan WenZilong WangYingkun XuXunbo JinXiao YuMuwen Wang

Published in: OncoTargets and therapy (2021)

These data suggest that RPN2 functions as an oncogene to promote tumor development and is a promising prognostic factor and therapeutic target in BCa.

Keyphrases

poor prognosis
prognostic factors
long non coding rna
electronic health record
big data
machine learning
deep learning
artificial intelligence